Ryzodeg FlexTouch (combination of 70% Insulin degludec/ 30% Insulin aspart) - 100u/mL 5 x 3ml Pens

Ryzodeg FlexTouch is a medication used to treat diabetes. It is a combination of two types of insulin: insulin degludec and insulin aspart. Insulin is a hormone that regulates the level of sugar in the blood. Ryzodeg FlexTouch is used to help control high blood sugar levels in people with type 1 or type 2 diabetes. Insulin degludec is a long-acting insulin that works by lowering the amount of glucose produced by the liver and increasing the uptake of glucose into the body's cells. Insulin aspart is a fast-acting insulin that works by lowering blood sugar levels after a meal. Ryzodeg FlexTouch is injected under the skin using a pre-filled pen device. The dosage and timing of injections will depend on the individual's blood sugar levels and other factors such as diet and exercise. As with all medications, Ryzodeg FlexTouch may cause side effects such as hypoglycemia (low blood sugar), allergic reactions, and injection site reactions. It is important to follow your healthcare provider's instructions and to monitor your blood sugar levels closely while using this medication.

FDA insulin storage recommendations. Insulin products contained in vials or cartridges supplied by the manufacturers (opened or unopened) may be left unrefrigerated at a temperature between 59°F and 86°F for up to 28 days and continue to work.